Praxis Precision Medicines, Inc.
NASDAQ:PRAX
38.57 (USD) • At close March 12, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 8.553 | 2.447 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 1.171 | 1.594 | 0.746 | 0.679 | 0.001 |
| Gross Profit
| 8.553 | 2.447 | -1.171 | -1.594 | -0.746 | -0.679 | -0.001 |
| Gross Profit Ratio
| 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 152.413 | 86.766 | 155.04 | 120.257 | 44.976 | 29.557 | 18.82 |
| General & Administrative Expenses
| 56.305 | 42.054 | 59.946 | 47.075 | 16.992 | 6.232 | 3.899 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 56.305 | 42.054 | 59.946 | 47.075 | 16.992 | 6.232 | 3.899 |
| Other Expenses
| 0 | 0 | 0.957 | 0.271 | 0.14 | 0 | -3.648 |
| Operating Expenses
| 208.718 | 128.82 | 214.986 | 167.332 | 61.968 | 35.789 | 22.719 |
| Operating Income
| -200.165 | -126.373 | -214.986 | -167.332 | -61.968 | -35.789 | -22.719 |
| Operating Income Ratio
| -23.403 | -51.644 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 17.346 | 3.096 | 0.957 | 0.271 | 0.14 | 0.193 | -3.683 |
| Income Before Tax
| -182.819 | -123.277 | -214.029 | -167.061 | -61.828 | -35.596 | -26.402 |
| Income Before Tax Ratio
| -21.375 | -50.379 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | -0.957 | -0.182 | -0.008 | -0.084 | 0.133 |
| Net Income
| -182.819 | -123.277 | -213.072 | -166.879 | -61.82 | -35.512 | -26.535 |
| Net Income Ratio
| -21.375 | -50.379 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -10.21 | -18.69 | -69.33 | -58.96 | -103.61 | -348.24 | -306.73 |
| EPS Diluted
| -10.21 | -18.69 | -69.33 | -58.96 | -103.61 | -348.24 | -306.73 |
| EBITDA
| -200.165 | -125.941 | -212.858 | -165.467 | -61.082 | -34.917 | -26.274 |
| EBITDA Ratio
| -23.403 | -51.468 | 0 | 0 | 0 | 0 | 0 |